Intrauterine insemination (IUI) is the therapeutic process of placing washed spermatozoa transcervically into the uterine cavity for the treatment of infertility. IUI theoretically allows a relatively higher number of motile spermatozoa to reach the oocyte. This study is a cross sectional prospective study done on 52 cases in newly started Dhaka Medical College Hospital Fertility Care Centre from October 2015 to March 2016. Among the 52 cases 4 cases became pregnant by IUI (7.7%) which is equivalent to the success rate observed in other established centers. The outcome suggests that IUI is possible in a relatively new center with limited technology setting. It may be considered as a good treatment option for couples with unexplained infertility, male factor infertility, and anovulation related infertility. Further improvement of this infertility center can bring better outcome in the treatment of infertility in the public sector.
Introduction
Intrauterine insemination (IUI) is the therapeutic process of placing washed spermatozoa transcervically into the uterine cavity for the treatment of infertility. IUI theoretically allows a relatively higher number of motile spermatozoa to reach the oocyte. 1 At present, 16% of prospective parents seek medical advice for infertility.
A combination of controlled ovarian hyperstimulation (COH) with intrauterine insemination (IUI) remains an important option available to an infertility specialist and is a widely used treatment modality for a broad range of indications. Common indications include cervical factor, mild endometriosis, mild to moderate male factor, ovulatory dysfunction and unexplained infertility. 1 The reported pregnancy rates per cycle range from 8 to 22%. [2] [3] [4] The pregnancy rates per IUI cycle are quite variable in the literature due to differences in cause and duration of infertility, concomitant usage or omission of ovarian stimulation, sperm preparation techniques, treatment cycles and number of times IUI is performed during a cycle (single or double). [1] [2] [3] [4] The cumulative pregnancy rates for COH with IUI vary according to the indications, and are in the range of 20-33%. 4, 5 Generally, four cycles of COH/IUI are recommended depending on the age of female prior to moving on to assisted reproductive technology (ART)-in vitro fertilization (IVF). 3, 6 Even though COH/IUI is a less expensive and simpler form of treatment compared with ART-IVF, it still requires frequent monitoring and supervision under specialist care.The knowledge that the per-cycle pregnancy rates are not very encouraging combined with the time, effort and financial implications of such treatment, attempting a COH/IUI cycle could be a challenging decision for the couple. Method: Before each course of treatment, the following tests were performed, Serum hormone assays (FSH, LH) on the 2nd day of the menstrual cycle.TSH, USG of lower abdomen, Hysterosalpingography/ laparoscopy, semen analysis of husband.
Material and Method:
In this case study 52 patient were treated by clomiphene citrate, /aromatoze inhibitor / clomiphene citrate +HCG, / aromatoze r inhibitor+HCG, / FSH. +HCG On the day of IUI, the husband was instructed to give a semen that was prepared by swip up or double-density gradient method with Pure sperm, The postwash sample parameters were assessed. Under aseptic precautions, IUI was carried out with a soft IUI catheter , with an insemination volume of 0.5ml. After the procedure, the patient was advised 20 minutes of bed rest. All women were provided luteal phase support with natural micronized progesterone vaginal pessaries for 16 days. If menstrual cycle was delayed, urine pregnancy test was carried out. When positive, a transvaginal ultrasound was performed 2 weeks later to confirm a clinical pregnancy. Clinical pregnancy was defined as the presence of an intrauterine gestational sac, confirmed by ultrasound. Higher-order pregnancies were defined as three or more gestational sacs visualized at ultrasound.
Results
This observational study was performed on 52 couples attended at DMCH fertility care centre . Appropriate statistical technique was used for data analysis. Results were presented with tables and graphs where applicable.
Socio demographic characteristics of respondents

Age
Here age of the female respondent was taken. Minimum and maximum age of them were 20 and 36 accordingly. Mean age was 28.71± 4.58 years. Maximum number of respondent (15.4%) aged 30 years. Age was ranged with proportion of respondents in d" 20 (5.8%), 21-25 (25%), 26-30 (36.5%), 31-35 (26.9%) and e" 30 (5.8%) accordingly.
Education:
Maximum number of respondent (55.8%) had education up to HSC or more than this level. Where as the number of illiterate ( 28.8%) and up to SSC level (15.4%) were accordingly. 
Infertility status(Type and cause of infertility)
Proportion of primary subfertility (67.3%) with its average duration (6.20± 3.92) was more than secondary subfertility (32.7%) and its duration (5.41± 3.33).
Out of 52 cases of infertility, 50%were due to female cause, 34.6% due to male cause and rest 15.4% were due to any unknown cause. Average duration of infertility due to male, female and unknown cause was almost equal (6.00± 3.76 years, 6.63± 5.39 years and 5.69±3.22 years). It was seen that among the male factor proportion of oligospermia (30.8%) was higher than other factors (3.8%).
Types of subfertility
Female cause was assessed by diagnostic test which included ultrasonography, by TVS, hysterosalpingography and or laparoscopy. In ultrasonography the proportion of poly cystic ovarian syndrome ( 28.8%) was more than pelvic inflammatory disease (11.5%), fibroid (5.8%) and endometriosis (3.8%) accordingly .
In hysterosalpingography only one patient (1.9%) was diagnosed with one tubual block. Where as in laparoscopy three patient were diagnosed to have one tubual block (5.8%).
Controlled ovarian stimualation was done with aromatase inhibitor (90.4%), Folicle stimulating hormone (73.1%), clomifen citrate(13.5%) .These drugs were given in combination. Maximum number of patients who were treated with drugs for infertility, got the combination of two drug (71.2%) and rest of them with the combination of three drug (25%). Inj Human chorionic gonadotrophin was given to all patients on 13th days after doing the TVS.
Folliculometry was done by TVS among 52 female patner dominant follicles were varies from 20mm to. 26mm. Endometrial thickness of the respondents varies from 6to10mm. Average thickness of the endometrium was 9.35±4.004 mm. Of all the 52 respondent only 4 respondent (7.7%) became pregnant after treatment.
Semen parameter in IUI pre wash showed more oligospermia than post wash (21.2% and 19.2%). Where as proportion of asthenospermia was equal (1.9%).
consultancy USG, TVS, Hysterosalpingography. Indoor services are laparoscopy and hysteroscopy for both diagnostic as well as treatment purpose. In outdoor there is an Andrology Lab and IUI room for IUI. This IUI has started from July 2016, so far 52 cases have undergone IUI.
This study was based upon those 52 cases. Among these 52 cases 23(26.9%) females have come from 31-35 age group. Majority of the couples 35(67.3%) had primary subfertility while the rest 17(32.7%) secondary subfertility. Female factor was predominant 26(50%) followed by male factor 18(34.6%). Among the 52 cases 8(15.4%) couple have been found having both male and female factor. Analysis of female factors revealed that in this study main cause of female factors were anovulation due to PCOS (29%) followed by PID (11%) endometriosis (4%). While male factor analysis had revealed that most of the male suffered from oligospermia (30.8%) and coital difficulty (3.8%).
In this study among 52 cases of IUI 4 cases (7.7%) became pregnant, The pregnancy rate of IUI is reported to 10-20% per patient, but the reported rates range from as low as 5% to as high as 70%. 11 Based on the etiology of infertility, the highest rates were reported when IUI was used in patients with anovulation who were undergoing ovulation induction therapy at the time of the IUI treatment, male factor infertility, and unexplained infertility. In patients with endometriosis, the pregnancy rates were the lowest. 12 Those who became pregnant 2 had oligospermia & 2 were suffering from unexplained infertility. As part of IUI procedure most of the female patients underwent hysterosalpinography and laparoscopy for evaluation of tubal patency. Among 52 cases 31 females were given ovulation induction by Aromatase inhibitor (L) and human chronic gonadotropin hormone (HCG). 8 cases Clomiphene Citrate and HCG and 13 cases Aromatase inhibitor (L) and Follicular stimulating hormone and human chronoic gonadotropin hormone (HCG) for dominant follicle. Gonadotropins with and without gonadotropin-releasing hormone (GnRH) agonist/antagonist have been studied, along with recombinant human FSH (rFSH). Ragni et al. reported that the daily use of 50 IU of rFSH, combined with a GnRH antagonist, ganirelix, for ovarian stimulation prior to IUI resulted in a live birth rate per couple of 25.7%. 13 When the same dose of rFSH was used on alternate days, rFSH produced a live birth rate of 2.9%. 13 In another study, 50 IU daily of rFSH was found similar to 75 IU daily of urinary FSH (uFSH) in the outcomes of the number of follicles >17 mm and days of stimulation. 14 The clinical pregnancy rates were 12.7% for rFSH and 11.9% for The number of mature follicles (17 mm in diameter or more) is another prognostic factor in IUI success, where the presence of 3-4 mature follicles was associated with higher pregnancy rates and a lower incidence of high-order multiple pregnancies. 14 
Conclusion:
This study suggests that IUI may be effective in a newly developed medical setting. It may be considered as a good first-line invasive treatment for couples with unexplained infertility, male factor infertility, and patients with anovulation. More study with large number of population is needed to further establish the effectiveness of & success of IUI.
Recommendation:
Now a days worldwide infertility problem is increasing day by day. It is also a major problem for our country. However due to high expenses people suffering from infertility are mostly unable to avail this treatment. IUI service in Dhaka medical college offers infertility treatment almost free of cost which is within the reach of poor patients. Infertility centre of Dhaka Medical College has set an example for the other government hospitals and centers which should come forward with such low cost infertility treatment settings and thus provide IUI treatment for the low socio economic people of our country suffering from infertility.
